A 2025 analysis by the Employers Health Coalition found that 64% of large employers (5,000+ employees) excluded GLP-1 medications for obesity from their health plans, citing projected costs of $12,000 to $15,000 per patient per year (Jain et al., Health Affairs 2025)
Keep a water bottle accessible throughout the day and establish regular drinking habits
Safety Issues With Glucagon-Like Peptide-1 Receptor Agonists (Pancreatitis, Pancreatic Cancer and Cholelithiasis): Data From Randomized Controlled Trials
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
Small changes, done consistently, can add up to better appetite control, steadier energy, and more balanced blood sugarone meal at a time.
serum BUN was determined using the Bioassay systems assay (DIUR-100) according to the manufacturers directions